Mobile-health Network Solutions Secures US$900,000 Strategic Investment from Indopacific to Accelerate Lifepack Acquisition and Indonesia Market Entry

Rhea-AI Summary

Mobile-health Network Solutions (NASDAQ: MNDR) has secured a US$900,000 strategic investment from Indopacific Health Investment Corporation through a subscription of Class A ordinary shares at US$1.80 per share.

This investment follows Indopacific's initial US$150,000 subscription in May 2025, bringing their total investment to US$1.05 million. The funds will primarily support MNDR's planned acquisition of Lifepack, an Indonesian digital pharmacy platform, and facilitate the company's expansion into Southeast Asian markets.

Positive

• Secured significant strategic investment of US$900,000 from Indopacific
• Total investment from Indopacific increased to US$1.05 million, showing strong investor confidence
• Strategic acquisition of Lifepack will enable expansion into Indonesian market
• Partnership validates company's growth strategy in Southeast Asia

Negative

• Share issuance at US$1.80 may cause dilution for existing shareholders

Singapore, Singapore--(Newsfile Corp. - September 11, 2025) - Mobile-health Network Solutions (NASDAQ: MNDR) ("MNDR" or the "Company"), a leading AI-powered digital health platform, today announced that Indopacific Health Investment Corporation Pte. Ltd. ("Indopacific") has subscribed for US$900,000 worth of Class A ordinary shares, marking a significant expansion of its investment in MNDR and reinforcing its commitment to the Company's regional growth strategy.

The share purchase was executed under a Securities Purchase Agreement dated September 10, 2025, with shares priced at US$1.80 each. The transaction includes customary closing conditions and lock-up provisions aligned with Nasdaq requirements.

This latest capital injection follows Indopacific's initial US$150,000 subscription in May 2025, bringing its total investment in MNDR to US$1.05 million. The funds will be used to finance the Company's planned acquisition of Lifepack, a leading digital pharmacy platform in Indonesia, and to support MNDR's broader market entry initiatives across Southeast Asia.

"Our partnership with Indopacific is built on a shared belief in the transformative potential of digital healthcare," said Dr. Siaw Tung Yeng, Co-founder and Co-Chief Executive Officer of MNDR. "Indopacific has recognized the intrinsic value of our platform and is working closely with us to unlock new opportunities in Indonesia. This investment not only validates our strategic direction but also accelerates our ability to deliver high-impact solutions to underserved communities."

About Mobile-health Network Solutions

Mobile-health Network Solutions is a leading AI-powered digital health platform headquartered in Singapore, with operations across Southeast Asia and expanding into the US. The company provides telemedicine, AI-driven health tools, and virtual clinic infrastructure to empower patients and doctors worldwide. Its mission is to make healthcare accessible, intelligent, and human - through technology. For more information, please visit our website.

Forward-Looking Statements

Certain statements contained in this press release about future expectations, plans and prospects, as well as any other statements regarding matters that are not historical facts, may constitute "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. These statements include, but are not limited to, statements relating to the expected trading commencement and closing dates. The words "anticipate," "believe," "continue," "could," "estimate," "expect," "intend," "may," "plan," "potential," "predict," "project," "should," "target," "will," "would" and similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words. Forward-looking statements are not guarantees of future performance and involve risks and uncertainties that may cause the actual results to differ materially from the Company's expectations discussed in the forward-looking statements. These statements are subject to uncertainties and risks including, but not limited to, the following: the Company's ability to execute our strategies, manage growth and maintain our corporate culture; the Company's future business development, financial conditions and results of operations; expectations regarding demand for and market acceptance of our products and services; changes in technology; economic conditions; the growth of the telehealth solutions industry in Singapore and the other international markets the Company plans to serve; reputation and brand; the impact of competition and pricing; government regulations; fluctuations in general economic and business conditions in Singapore and the international markets the Company plans to serve and assumptions underlying or related to any of the foregoing and other risks contained in reports filed by the Company with the SEC. For these reasons, among others, investors are cautioned not to place undue reliance upon any forward-looking statements in this press release. Any forward-looking statements contained in this press release speak only as of the date hereof, and Mobile-health Network Solutions specifically disclaims any obligation to update any forward-looking statement, whether because of new information, future events or otherwise, except as required by law.

For media inquiries, please contact:
Mobile-health Network Solutions Investor Relations Contact:
2 Venture Drive, #07-06/07 Vision Exchange
Singapore 608526
(+65) 6222 5223
Email: investors@manadr.com

Investor Relations Inquiries:
Skyline Corporate Communications Group, LLC
Scott Powell, President
1177 Avenue of the Americas, 5^th Floor
New York, New York 10036
Office: (646) 893-5835
Email: info@skylineccg.com

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/266033

FAQ

How much did Indopacific invest in Mobile-health Network Solutions (MNDR)?

Indopacific invested US$900,000 in this round, bringing their total investment to US$1.05 million including their previous US$150,000 investment from May 2025.

What is the purpose of MNDR's latest investment round?

The investment will fund the acquisition of Lifepack, an Indonesian digital pharmacy platform, and support MNDR's market entry initiatives across Southeast Asia.

What is the share price for MNDR's latest investment round?

The Class A ordinary shares were priced at US$1.80 per share under the Securities Purchase Agreement dated September 10, 2025.

Who is Lifepack and why is MNDR acquiring them?

Lifepack is a leading digital pharmacy platform in Indonesia. The acquisition will enable MNDR to expand its presence in the Indonesian market.

What are the terms of MNDR's investment agreement with Indopacific?

The agreement includes customary closing conditions and lock-up provisions aligned with Nasdaq requirements, with shares priced at US$1.80 each.